![Greg Harriman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Greg Harriman
Direktor/Vorstandsmitglied bei
Treventis Corp.
Profil
Greg Harriman is currently an Independent Director at Treventis Corp.
and a Partner at The Biotechnology Greenhouse Corp.
of Southeastern PA since 2012.
Former positions include Executive Director at Centocor, Inc. (2001), Director at IVAX LLC (1998), Director at Immunome, Inc., Vice President at Johnson & Johnson (2009), Principal at Robin Hood Ventures, Assistant Professor at Baylor College of Medicine (1996), and Vice President at Therakos LLC (2009).
Education includes an undergraduate degree from the University of California, Berkeley (1977) and a doctorate from the University of California San Diego (1981).
Aktive Positionen von Greg Harriman
| Unternehmen | Position | Beginn |
|---|---|---|
The Biotechnology Greenhouse Corp. of Southeastern PA
 The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance BioAdvance invests in companies located in the United States, primarily in New York and Washington, D.C. The firm targets companies operating in the fields of medical devices, digital health, diagnostics and research tools in healthcare sector. It provides financing for seed and early stage capital requirements with an investment size of USD 0.5 - 5 million and also acts as lead investor. | Private Equity Investor | - |
Treventis Corp.
 Treventis Corp. BiotechnologyHealth Technology Develops a small molecule drugs for Alzheimer’s and other protein misfolding diseases | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Greg Harriman
| Unternehmen | Position | Ende |
|---|---|---|
| JOHNSON & JOHNSON | Corporate Officer/Principal | 31.12.2009 |
Therakos, Inc.
 Therakos, Inc. BiotechnologyHealth Technology Develops extracorporeal photopheresis delivery system for autologous immunomodulatory therapy | Corporate Officer/Principal | 31.12.2009 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Corporate Officer/Principal | 31.07.2001 |
IVAX LLC
 IVAX LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures & markets branded and generic pharmaceuticals | Direktor/Vorstandsmitglied | 30.06.1998 |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 30.06.1996 |
Ausbildung von Greg Harriman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
IVAX LLC
IVAX LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures & markets branded and generic pharmaceuticals | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Robin Hood Ventures
 Robin Hood Ventures Investment ManagersFinance RHV invests in companies located in the United States. The firm targets companies operating in the fields of consumer products, information tech, biotechnology, hardtechnology, healthcare and medical devices. It provides financing for seed and early stage capital requirements with an investment size ranging between USD 0.5 - 3 million. It also makes follow on investments and takes a board seat. | Finance |
The Biotechnology Greenhouse Corp. of Southeastern PA
The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance BioAdvance invests in companies located in the United States, primarily in New York and Washington, D.C. The firm targets companies operating in the fields of medical devices, digital health, diagnostics and research tools in healthcare sector. It provides financing for seed and early stage capital requirements with an investment size of USD 0.5 - 5 million and also acts as lead investor. | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Therakos, Inc.
Therakos, Inc. BiotechnologyHealth Technology Develops extracorporeal photopheresis delivery system for autologous immunomodulatory therapy | Health Technology |
Treventis Corp.
Treventis Corp. BiotechnologyHealth Technology Develops a small molecule drugs for Alzheimer’s and other protein misfolding diseases | Health Technology |
